.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Novartis
Boehringer Ingelheim
Farmers Insurance
Johnson and Johnson
Chubb
Deloitte
Citi
McKesson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202811

« Back to Dashboard
NDA 202811 describes LINZESS, which is a drug marketed by Forest Labs Llc and is included in one NDA. It is available from three suppliers. There are nine patents protecting this drug and one Paragraph IV challenge. Additional details are available on the LINZESS profile page.

The generic ingredient in LINZESS is linaclotide. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the linaclotide profile page.

Summary for NDA: 202811

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 202811

Mechanism of ActionGuanylate Cyclase Activators

Suppliers and Packaging for NDA: 202811

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LINZESS
linaclotide
CAPSULE;ORAL 202811 NDA Allergan, Inc 0456-1201 0456-1201-04 1 BOTTLE in 1 CARTON (0456-1201-04) > 4 CAPSULE, GELATIN COATED in 1 BOTTLE
LINZESS
linaclotide
CAPSULE;ORAL 202811 NDA Allergan, Inc 0456-1201 0456-1201-30 1 BOTTLE in 1 CARTON (0456-1201-30) > 30 CAPSULE, GELATIN COATED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength145MCG
Approval Date:Aug 30, 2012TE:RLD:Yes
Patent:7,304,036Patent Expiration:Jan 28, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:7,371,727Patent Expiration:Jan 28, 2024Product Flag?Substance Flag?YDelist Request?
Patent:7,704,947Patent Expiration:Jan 28, 2024Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Fish and Richardson
US Department of Justice
Healthtrust
QuintilesIMS
Cerilliant
UBS
McKinsey
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot